Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
891.9500
20.15
(
2.31
%)
NSE
Jan 14, 2026
15:31 PM
33.49% Fall from 52W High
Volume:
460.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
05 Dec 2022
891.95
2.31%
NATCO PHARMA
Buy:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 704
Recommendation
Target
Geojit BNP Paribas
Natco Pharma Ltd. is trading
above its 200 day SMA
of 876.0
More from Natco Pharma Ltd.
Recommended
Market closes lower, amid foreign fund outflows & US tariff threats on Iranian trading partners
Trendlyne Marketwatch |
14 Jan 2026, 04:03PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020